Get started
Author

Bettina Gisslinger

Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
2013 · Thorsten Klampfl, Heinz Gisslinger, et al. · New England Journal of Medicine · 2,003
PDF
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
2013 · A Tefferi, E Rumi, et al. · Leukemia · 702
PDF
A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms
2009 · Damla Olcaydu, Ashot Harutyunyan, et al. · Nature Genetics · 362
Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms
2015 · Jelena D. Milosevic Feenstra, Harini Nivarthi, et al. · Blood · 284
A prognostic model to predict survival in 867 World Health Organization–defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment
2012 · Francesco Passamonti, Jürgen Thiele, et al. · Blood · 277
PDF
Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera
2015 · Heinz Gisslinger, Oleh Zagrijtschuk, et al. · Blood · 193
Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis
2020 · Georg Greiner, Bettina Sprinzl, et al. · Blood · 189
Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression
2011 · Thorsten Klampfl, Ashot Harutyunyan, et al. · Blood · 185
PDF
Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification
2011 · Jürgen Thiele, Hans Michael Kvasnicka, et al. · Blood · 183
Long non-coding RNAs display higher natural expression variation than protein-coding genes in healthy humans
2016 · Aleksandra E. Kornienko, Christoph P. Dotter, et al. · Genome biology · 170
PDF
In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology
2014 · Tiziano Barbui, Alessandra Carobbio, et al. · Blood · 161
PDF
Masked polycythemia Vera (mPV): Results of an international study
2013 · Tiziano Barbui, Jürgen Thiele, et al. · American Journal of Hematology · 152
Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy
2018 · Edit Porpaczy, Sabrina Tripolt, et al. · Blood · 151
PDF
Deletions of the transcription factor Ikaros in myeloproliferative neoplasms
2010 · R Jäger, H Gisslinger, et al. · Leukemia · 138
Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome
2012 · Tiziano Barbui, Jürgen Thiele, et al. · Blood · 108
Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies
2011 · Ana Puda, Jelena D. Milosevic, et al. · American Journal of Hematology · 105
PDF
Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational status
2017 · B Kubesova, S Pavlova, et al. · Leukemia · 82
PDF
Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early/prefibrotic primary myelofibrosis
2012 · Tiziano Barbui, Jürgen Thiele, et al. · Blood · 80
PDF
Masked polycythemia vera diagnosed according to WHO and BCSH classification
2013 · Tiziano Barbui, Jürgen Thiele, et al. · American Journal of Hematology · 79
Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases
2019 · Emanuela Sant'Antonio, Paola Guglielmelli, et al. · American Journal of Hematology · 78
PDF
Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasms
2019 · Fiorella Schischlik, Roland Jäger, et al. · Blood · 78
Clinical significance of genetic aberrations in secondary acute myeloid leukemia
2012 · Jelena D. Milosevic, Ana Puda, et al. · American Journal of Hematology · 78
PDF
Arsenic trioxide and ascorbic acid: synergy with potential implications for the treatment of acute myeloid leukaemia?
2001 · T. Bachleitner‐Hofmann, B. Gisslinger, et al. · British Journal of Haematology · 69
Pre‐fibrotic/early primary myelofibrosis vs. WHO‐defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease
2017 · Georg Jeryczynski, Jürgen Thiele, et al. · American Journal of Hematology · 68
PDF
The effect of arterial hypertension on thrombosis in low‐risk polycythemia vera
2016 · Tiziano Barbui, Alessandro M. Vannucchi, et al. · American Journal of Hematology · 67
PDF
Works count: 130
Citation count: 6,993
H-index: 33
I10-index: 56
Year
Topic
Type